Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol KCNN4 contributors: mct - updated : 25-08-2015
HGNC name potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4
HGNC id 6293
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
9 - 2240 47.6 427 - -
EXPRESSION
Type
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Digestiveesophagus   moderately
 intestine   highly Homo sapiens
Endocrinepancreas   highly
Lymphoid/Immunespleen    
Reproductivefemale systemuteruscervix moderately
 female systemplacenta  predominantly
 male systemprostate  highly
tissue
SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
Blood / hematopoieticbone marrow  highly
Connectivebone  moderately
cells
SystemCellPubmedSpeciesStageRna symbol
Digestiveepithelial cell Homo sapiens
Lymphoid/Immunelymphocyte
cell lineage
cell lines ovarian tumors
fluid/secretion moderately in lymph
at STAGE
physiological period fetal, pregnancy
Text liver, placenta
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • six putative transmembrane domains
  • a conserved porc region
  • a leucine zipper-like motif near the C terminus
  • mono polymer heteromer , tetramer
    HOMOLOGY
    interspecies homolog to rattus Kcnn4 (85.8 pc)
    homolog to murine Kcnn4 (87.5 pc)
    Homologene
    FAMILY
  • SK channel family
  • potassium channel KCNN family
  • CATEGORY immunity/defense , transport channel
    SUBCELLULAR LOCALIZATION     plasma membrane
    text
  • multi-pass membrane protein
  • KCNN4 channels in the apical membrane of intestinal epithelial cells
  • basic FUNCTION
  • acting as a voltage-independent potassium channel
  • plays an important role in T lymphocyte Ca(2+) signaling by helping to maintain a negative membrane potential, which provides an electrochemical gradient to drive Ca(2+) influx
  • involved in lung dendritic cells migration to lymphatic chemokines
  • KCNN4 channel in the apical and basolateral membranes of epithelial cells play important roles in agonist-induced fluid secretion in intestine and colon
  • plays a key role in human fibrocyte migration
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS development , immunity/defense
    text K+ transport
    PATHWAY
    metabolism
    signaling
    a component
  • heterotetramer of potassium channel proteins
  • INTERACTION
    DNA
    RNA
    small molecule
    protein
  • binding to calmodulin
  • functional link between KCNN4 and PRKAG1 (regulation of KCNN4 by AMPK in a functional epithelium through protein/protein interactions)
  • time-dependent association between KCNN4 and USP8 following endocytosis
  • both PI3KC2B and TRIM27 play critical but opposite roles in FCER1A-stimulated activation of KCNN4, Ca2+ influx, degranulation, and cytokine production in bone marrow mast cells
  • by dephosphorylating NME2, PGAM5 negatively regulates CD4(+) T cells by inhibiting NME2-mediated histidine phosphorylation and activation of the KCNN4
  • cell & other
    REGULATION
    activated by intracellular calcium
    induced by phorbol myristate acetate (PMA) and phytohemagglutinin (PHA) in T-cells
    Other blocked by clotrimazole and charybdotoxin
    ASSOCIATED DISORDERS
    corresponding disease(s) DHS2
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in pancreas and ovarian tumors
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    allergyasthm 
    currently available KCNN4 blockers might therefore attenuate tissue fibrosis and remodeling in patients with diseases such as idiopathic pulmonary fibrosis and asthma through the inhibition of fibrocyte recruitment
    immunologyautoimmunedigestive
    it may be possible to rapidly test whether KCa3.1 inhibitors are efficacious in patients with inflammatory bowel diseases such as Crohn disease and ulcerative colitis
    cardiovascularatheroma 
    CKCNN4 blockers represent a promising therapeutic strategy for atherosclerosis.
    miscelleaneousurinarychronic kidney disease
    pharmacological inhibitors of KCNN4 channels may provide a novel and effective therapy to delay progression to kidney failure in patients with ADPKD
    ANIMAL & CELL MODELS